EIDD-1931 (NHC) is an active metabolite of EIDD-2801, a promising COVID-19inhibitor. EIDD-1931 (NHC) has broad spectrum antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV, and related zoonotic group 2bor 2c Bat-CoVswith average IC50 of 0.15 μM, as well as increased potency against a coronavirus bearing resistance mutations to the nucleoside analog inhibitor remdesivir.
Price | 2.125,00 RON (preturile sunt fara TVA) |
---|---|
Description |
EIDD-1931 (NHC) is an active metabolite of EIDD-2801, a promising COVID-19inhibitor. EIDD-1931 (NHC) has broad spectrum antiviral activity against SARS-CoV-2, MERS-CoV, SARS-CoV, and related zoonotic group 2bor 2c Bat-CoVswith average IC50 of 0.15 μM, as well as increased potency against a coronavirus bearing resistance mutations to the nucleoside analog inhibitor remdesivir. |